Aytu BioPharma (AYTU) Stock Chart & Stock Price History $1.91 -0.03 (-1.55%) (As of 11/4/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Aytu BioPharma Stock Price Performance5 Day Performance-4.02%1 Month Performance-18.72%3 Month Performance-24.21%6 Month Performance-36.54%Year-To-Date Performance-32.75%1 Year Performance-34.14% Receive AYTU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aytu BioPharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt to discredit it, tar and feather it, and convince you not to watch it. That’s because it tells the shocking truth about the current AI mania… and why investors in big tech companies like Nvidia, Meta, Alphabet, and Microsoft could be in for a whole world of pain.Here’s the full story for you. AYTU Stock Chart for Monday, November, 4, 2024 AYTU Chart by TradingView Aytu BioPharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/04/2024$1.94$1.91-1.42%$2.04$1.9040,922 shs$11.75 million11/01/2024$1.92$1.94+0.91%$2.03$1.919,053 shs$11.91 million10/31/2024$1.99$1.92-3.52%$1.97$1.9017,112 shs$11.47 million10/30/2024$2.00$1.99-0.25%$2.09$1.9710,625 shs$11.88 million10/29/2024$2.08$2.00-4.09%$2.15$1.9547,523 shs$11.91 million10/28/2024$2.16$2.08-3.92%$2.15$2.0527,767 shs$12.42 million Get the Latest News and Ratings for AYTU and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aytu BioPharma and its competitors with MarketBeat's FREE daily newsletter. 10/25/2024$2.15$2.11-1.86%$2.17$2.106,201 shs$12.60 million10/24/2024$2.13$2.15+0.94%$2.21$2.1010,795 shs$12.84 million10/23/2024$2.19$2.13-2.74%$2.16$2.1018,348 shs$12.72 million10/22/2024$2.22$2.19-1.35%$2.27$2.0422,788 shs$13.08 million10/21/2024$2.29$2.22-3.06%$2.30$2.2023,566 shs$13.26 million10/18/2024$2.29$2.29$2.31$2.277,189 shs$13.68 million10/17/2024$2.33$2.29-1.72%$2.36$2.2910,795 shs$13.68 million10/16/2024$2.29$2.33+1.75%$2.38$2.268,272 shs$13.92 million10/15/2024$2.26$2.29+1.33%$2.38$2.2518,924 shs$13.68 million10/14/2024$2.24$2.26+0.89%$2.28$2.263,435 shs$13.50 million10/11/2024$2.24$2.24$2.28$2.2012,190 shs$13.78 million10/10/2024$2.20$2.24+1.82%$2.29$2.1121,910 shs$13.38 million10/09/2024$2.35$2.20-6.38%$2.34$2.2013,928 shs$13.14 million10/08/2024$2.34$2.35+0.43%$2.35$2.259,326 shs$14.03 million10/07/2024$2.35$2.34-0.43%$2.44$2.3321,869 shs$13.97 million10/04/2024$2.40$2.35-2.08%$2.41$2.3527,236 shs$14.03 million10/03/2024$2.44$2.40-1.64%$2.45$2.382,611 shs$14.33 million10/02/2024$2.35$2.44+3.83%$2.47$2.3418,132 shs$14.57 million10/01/2024$2.35$2.35$2.38$2.2654,191 shs$14.03 million09/30/2024$2.36$2.35-0.42%$2.43$2.3421,111 shs$14.03 million09/27/2024$2.85$2.36-17.16%$2.60$2.30237,671 shs$14.09 million09/26/2024$2.43$2.85+17.24%$2.85$2.4952,367 shs$17.01 million09/25/2024$2.43$2.43$2.50$2.4110,182 shs$14.51 million09/24/2024$2.42$2.43+0.41%$2.52$2.3928,916 shs$14.51 million09/23/2024$2.45$2.42-1.22%$2.48$2.359,692 shs$14.45 million09/20/2024$2.40$2.45+2.08%$2.57$2.3732,023 shs$14.63 million09/19/2024$2.47$2.40-2.83%$2.55$2.359,740 shs$14.33 million09/18/2024$2.53$2.47-2.37%$2.53$2.4513,269 shs$14.75 million09/17/2024$2.59$2.53-2.32%$2.59$2.446,328 shs$15.11 million09/16/2024$2.58$2.59+0.39%$2.59$2.4015,672 shs$15.46 million09/13/2024$2.52$2.58+2.38%$2.58$2.553,026 shs$15.40 million09/12/2024$2.51$2.52+0.40%$2.57$2.4110,800 shs$15.05 million09/11/2024$2.48$2.51+1.21%$2.51$2.456,523 shs$14.99 million09/10/2024$2.43$2.48+2.06%$2.48$2.447,356 shs$14.81 millionThe Final Frontier (Ad)And a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt to discredit it, tar and feather it, and convince you not to watch it. That’s because it tells the shocking truth about the current AI mania… and why investors in big tech companies like Nvidia, Meta, Alphabet, and Microsoft could be in for a whole world of pain.Here’s the full story for you.09/09/2024$2.39$2.43+1.67%$2.49$2.383,310 shs$14.51 million09/06/2024$2.40$2.39-0.42%$2.41$2.378,726 shs$14.27 million09/05/2024$2.39$2.40+0.42%$2.45$2.3915,530 shs$14.33 million09/04/2024$2.49$2.39-4.02%$2.50$2.335,581 shs$14.27 million09/03/2024$2.50$2.49-0.40%$2.50$2.399,007 shs$14.87 million09/02/2024$2.50$2.50$2.50$2.3614,900 shs$14.93 million08/30/2024$2.40$2.44+1.67%$2.50$2.3614,992 shs$14.57 million08/29/2024$2.41$2.40-0.41%$2.47$2.407,930 shs$14.33 million08/28/2024$2.36$2.41+2.12%$2.44$2.337,594 shs$14.39 million08/27/2024$2.37$2.36-0.42%$2.40$2.3511,417 shs$14.09 million08/26/2024$2.44$2.37-2.87%$2.47$2.3414,667 shs$14.15 million08/23/2024$2.47$2.44-1.21%$2.50$2.3348,844 shs$14.57 million08/22/2024$2.69$2.47-8.18%$2.73$2.4663,275 shs$14.75 million08/21/2024$2.75$2.69-2.18%$2.80$2.6832,115 shs$16.07 million08/20/2024$2.63$2.75+4.56%$2.79$2.6424,922 shs$16.42 million08/19/2024$2.64$2.63-0.38%$2.73$2.607,379 shs$15.71 million08/16/2024$2.60$2.64+1.69%$2.69$2.568,680 shs$15.77 million08/15/2024$2.50$2.60+3.84%$2.60$2.4226,927 shs$15.50 million08/14/2024$2.42$2.50+3.41%$2.56$2.3930,821 shs$14.93 million08/13/2024$2.37$2.42+2.00%$2.43$2.406,363 shs$14.44 million08/12/2024$2.39$2.37-0.84%$2.42$2.3610,253 shs$14.15 million08/09/2024$2.41$2.39-0.83%$2.48$2.397,961 shs$14.27 million08/08/2024$2.46$2.41-2.22%$2.45$2.415,300 shs$14.39 million08/07/2024$2.48$2.46-0.61%$2.60$2.438,794 shs$14.72 million08/06/2024$2.44$2.48+1.64%$2.61$2.4126,282 shs$14.81 million08/05/2024$2.52$2.44-3.17%$2.52$2.3955,171 shs$14.57 million Related Companies LAVA Therapeutics Stock Price Chart Unicycive Therapeutics Stock Price Chart DURECT Stock Price Chart Immix Biopharma Stock Price Chart Clene Stock Price Chart Atara Biotherapeutics Stock Price Chart ProPhase Labs Stock Price Chart Rallybio Stock Price Chart CalciMedica Stock Price Chart Carisma Therapeutics Stock Price Chart Receive AYTU Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aytu BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AYTU) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aytu BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aytu BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
